Aurobindo Pharma’s Stock Hits Five-Year Low On U.S. FDA Observations For Hyderabad Unit
Capsules are laid out for inspection on the production line of a drug factory. (Photographer: Tomohiro Ohsumi/Bloomberg)

Aurobindo Pharma’s Stock Hits Five-Year Low On U.S. FDA Observations For Hyderabad Unit

Shares of Aurobindo Pharma Ltd. fell to their lowest in five years after the drugmaker said it received 14 observations from the U.S. health regulator for its manufacturing facility at Hyderabad—a ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.